Can trazodone be used safely in patients with adrenal insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Trazodone Can Be Used in Adrenal Insufficiency, But With Important Caveats

Trazodone is not contraindicated in adrenal insufficiency and can be used safely, but clinicians must be aware that it suppresses cortisol production and may worsen hypotension—both of which could theoretically precipitate or mask an adrenal crisis in vulnerable patients.

Key Pharmacological Considerations

Cortisol Suppression Effects

Trazodone has documented effects on the hypothalamic-pituitary-adrenal (HPA) axis through its alpha-1 adrenergic antagonism:

  • In humans, trazodone (75 mg) significantly decreases plasma cortisol concentrations, with a strong negative correlation between drug levels and cortisol (r = -0.95) 1
  • In dogs, single-dose trazodone significantly reduced post-ACTH stimulation cortisol response and delta cortisol concentrations, demonstrating dampened adrenocortical responsiveness 2

This cortisol-suppressing effect is clinically relevant because patients with adrenal insufficiency already have impaired cortisol production. While trazodone won't cause adrenal insufficiency in someone with normal adrenal function, it could theoretically reduce the already-limited cortisol reserve in patients with established disease.

Hypotensive Effects

The FDA label does not specifically contraindicate trazodone in adrenal insufficiency 3. However, trazodone causes:

  • Low blood pressure as a recognized adverse effect 3
  • Orthostatic hypotension, particularly problematic in older adults—one 2025 study showed trazodone users had significantly greater systolic BP drops immediately after standing (23.8 vs 14.3 mmHg) and higher rates of syncope/falls (58.3% vs 21.2%) 4

This is concerning because hypotension is a cardinal feature of adrenal crisis 5, and the 2024 European Society of Endocrinology/Endocrine Society guidelines emphasize that adrenal crisis shock is typically resistant to inotropes and fluids without glucocorticoid treatment 5.

Clinical Decision Algorithm

When Trazodone Can Be Used Safely:

  1. Stable, well-controlled adrenal insufficiency on appropriate glucocorticoid replacement
  2. Patient has been educated on adrenal crisis recognition and sick-day rules 5
  3. No concurrent illness or stressors that increase adrenal crisis risk
  4. Blood pressure is stable without orthostatic symptoms
  5. Patient carries emergency glucocorticoid supplies

Red Flags Requiring Extra Caution:

  • Recent glucocorticoid dose changes or tapering below physiological replacement 5
  • Concurrent illness, infection, or physical stress—these are common adrenal crisis triggers 5
  • Baseline hypotension or orthostatic symptoms
  • Elderly patients (>65 years)—higher adrenal crisis risk 5 and more pronounced hypotensive effects from trazodone 4
  • Undiagnosed or newly diagnosed adrenal insufficiency where cortisol reserve is uncertain

Monitoring Strategy:

  • Start with lowest effective dose
  • Monitor blood pressure closely, especially orthostatic measurements
  • Educate patient that trazodone-induced dizziness/hypotension could mask early adrenal crisis symptoms
  • Consider stress-dose glucocorticoid coverage if initiating during illness
  • Ensure patient understands that severe stress, anxiety, or physical illness requires increased glucocorticoid dosing regardless of trazodone use 5

Critical Pitfall to Avoid

Do not attribute hypotension, dizziness, or fatigue solely to trazodone side effects in a patient with adrenal insufficiency. These symptoms overlap significantly with adrenal crisis presentation (hypotension, severe fatigue, impaired consciousness) 5. When in doubt, treat presumptively with stress-dose glucocorticoids—the 2024 guidelines emphasize that short-term parenteral glucocorticoids are safe even if adrenal crisis is eventually ruled out 5.

Special Populations

The FDA label notes trazodone should be used with caution in renal and hepatic impairment (though not studied in these populations) 3. No specific mention is made of adrenal insufficiency as a contraindication in the drug labeling 3.

Bottom Line

Trazodone is not prohibited in adrenal insufficiency, but its cortisol-suppressing and hypotensive effects require heightened vigilance. The primary concern is not that trazodone will directly cause adrenal crisis, but that it may reduce physiological reserve and create overlapping symptoms that delay recognition of true adrenal decompensation. Use it when clinically indicated, but ensure robust patient education, appropriate glucocorticoid replacement, and close monitoring for signs of adrenal crisis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.